The association between concurrent psychotropic medications and self-reported adherence with taking a mood stabilizer in bipolar disorder
Objective Multiple psychotropic medications are routinely prescribed to treat bipolar disorder, creating complex medication regimens. This study investigated whether the daily number of psychotropic medications or the daily number of pills were associated with self‐reported adherence with taking a m...
Saved in:
Published in | Human psychopharmacology Vol. 25; no. 1; pp. 47 - 54 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.01.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective
Multiple psychotropic medications are routinely prescribed to treat bipolar disorder, creating complex medication regimens. This study investigated whether the daily number of psychotropic medications or the daily number of pills were associated with self‐reported adherence with taking a mood stabilizer.
Methods
Patients self‐reported their mood and medications taken daily for about 6 months. Adherence was defined as taking at least one pill of any mood stabilizer daily. Univariate general linear models (GLMs) were used to estimate if adherence was associated with the number of daily medications and the number of pills, controlling for age. The association between mean daily dosage of mood stabilizer and adherence was also estimated using a GLM.
Results
Three hundred and twelve patients (mean age 38.4 ± 10.9 years) returned 58,106 days of data and took a mean of 3.1 ± 1.6 psychotropic medications daily (7.0 ± 4.2 pills). No significant association was found between either the daily number of medications or the daily number of pills and adherence. For most mood stabilizers, patients with lower adherence took a significantly smaller mean daily dosage.
Conclusions
The number of concurrent psychotropic medications may not be associated with adherence in bipolar disorder. Patients with lower adherence may be taking smaller dosages of mood stabilizers. Copyright © 2009 John Wiley & Sons, Ltd. |
---|---|
Bibliography: | ark:/67375/WNG-RJRMH390-6 istex:C1DC2F3CA829A3428AEEAA4856142FCE008489B0 ArticleID:HUP1077 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0885-6222 1099-1077 |
DOI: | 10.1002/hup.1077 |